The report – which can be viewed here – highlights the following new medicines: 1) Novo Nordisk's Awiqli (LAI 287; insulin ... fixed-dose combination of an amylin analogue and GLP-1 agonist ...

GLP-1 medications initially were used to help people with diabetes improve their insulin resistance and hunger cravings.

Ascletis Pharma’s rapid-fire expansion into obesity drug development has passed another milestone. | Ascletis Pharma’s ...

Allurion Technologies (ALUR) announced its intention to initiate a clinical study on the combination of the Allurion Balloon with GLP-1 ...

For some, that extended to alcohol, too. Now, the growing buzz around the use of GLP-1 medications like Ozempic to treat alcohol use disorder finally has new clinical study results that support ...

• Glucagon-like peptide 1 receptor agonists (GLP-1) (medicines used to lower blood glucose) probably reduce the risk of death due to any cause but may have little or no death due to a heart attack in ...

GLP-1 medications initially were used to help people with diabetes improve their insulin resistance and hunger cravings.

Share on Pinterest GLP-1 and SGLT-2 drugs may be the best treatments for people with type 2 diabetes and COPD. Image credit: Visual Vic/Getty Images. Researchers estimate the number of people ...

GLP-1 therapies have demonstrated significant cardiometabolic benefits, particularly in high-risk patients with cardiovascular disease. Recent trials have shown the effectiveness of GLP-1 ...

BIRMINGHAM, Ala. (WBRC) - Glucagon-like peptide-1 (GLP-1) is a well-known medication used by physicians to treat Type 2 diabetes. GLP-1 has also become popular when used as a weight loss drug. But, ...

Novo Nordisk’s bid to provide a once-weekly basal insulin ... the FDA may approve insulin icodec for use in type 2 diabetes only, which is a much larger market than type 1, but the manufacturing ...

Clinical guidelines typically recommend against using sliding scale insulin as the sole method of insulin management. They instead recommend alternative methods, such as basal-bolus insulin.